文献速递妇产影像US

非典型性指数作为孕早期联合筛查染色体异常的附加指标

Atypicality index as an add-on to combined first-trimester screening for chromosomal aberrations.
PubMed 文献 · Ultrasound Obstet Gynecol · 2024-01-01

基于丹麦胎儿医学数据库145955例单胎妊娠,构建基于孕早期联合筛查标志物及孕中期估计胎儿体重的非典型性指数;筛查低危但非典型性高者染色体异常风险显著升高,典型者风险降低,指数可作为附加工具优化现有筛查资料解读。

要点

  • 筛查阴性且孕早期非典型性指数<80%者染色体异常风险0.28%,低于总体0.82%。
  • 筛查阴性者非典型性指数90-99%和≥99%亚组风险分别为1.52%和4.44%,均显著升高。
  • 联合孕中期估计胎儿体重的非典型性指数最异常两亚组风险分别为0.76%和4.16%。

核心结论

  • 非典型性指数作为孕早期联合筛查的附加指标,可识别测量谱典型的孕妇以提供 reassurance,非典型谱可能需专科转诊和进一步检查;筛查低危但非典型性高者染色体异常风险大幅增加。

研究设计与样本

  • 基于丹麦胎儿医学数据库的队列研究,纳入2008年1月至2018年12月丹麦中央 Denmark 地区所有接受孕早期联合筛查的单胎妊娠145955例,其中9824例(6.7%)接受遗传学检查,以细胞遗传学或分子分析为参考标准。

诊断标准与关键数值

  • 孕早期非典型性指数基于颈项透明层厚度、母血清游离β-hCG和妊娠相关血浆蛋白-A计算,0%代表最典型、100%代表最异常;联合孕中期估计胎儿体重的指数基于孕早期联合筛查标志物和孕中期常规畸形筛查的估计胎儿体重计算。

临床应用与阅片要点

  • 作者认为非典型性指数作为孕早期联合筛查的附加指标,可识别测量谱典型的孕妇以提供 reassurance,非典型谱可能需专科转诊和进一步检查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To compute a set of atypicality indices based on combined first-trimester screening (cFTS) markers and second-trimester estimated fetal weight (EFW), and to demonstrate their potential in identifying pregnancies at reduced or increased risk of chromosomal aberrations following a low-risk cFTS result.

METHODS: The atypicality index quantifies the unusualness of an individual set of measurements relative to a reference distribution and can be computed from any variables or measurements available. A score of 0% on the atypicality index represents the most typical profiles, while a score of 100% indicates the highest level of atypicality. From the Danish Fetal Medicine Database, we retrieved data on all pregnant women seen for cFTS in the Central Denmark Region between January 2008 and December 2018. All pregnancies with a cytogenetic or molecular analysis obtained prenatally, postnatally or following pregnancy loss or termination were identified. A first-trimester atypicality index (AcFTS) was computed based on nuchal translucency (NT) thickness, maternal serum free β-human chorionic gonadotropin (β-hCG) and pregnancy-associated plasma protein-A (PAPP-A). Furthermore, a second-trimester index (AcFTS + EFW) was computed from cFTS markers and EFW from a routine second-trimester anomaly scan. All pregnancies were stratified into subgroups based on their atypicality levels and their cFTS risk estimates. The risk of chromosomal aberrations in each subgroup was then compared with the overall prevalence, and a graphical presentation of the multivariate measurement profiles was developed.

RESULTS: We retrieved data on 145 955 singleton pregnancies, of which 9824 (6.7%) were genetically examined. Overall, 1 in 122 (0.82% (95% CI, 0.77-0.87%)) of all pregnancies seen for cFTS were affected by a fetal chromosomal aberration, and in screen-negative pregnancies (cFTS trisomy 21 risk < 1 in 100 and/or trisomy 18/13 risk < 1 in 50), 0.41% (95% CI, 0.38-0.44%) were affected. In screen-negative pregnancies with a typical first-trimester profile (AcFTS < 80%), the risk of chromosomal aberrations was significantly reduced (0.28%) compared with the overall risk. The risk of chromosomal aberrations increased with higher atypicality index to 0.49% (AcFTS [80-90%)), 1.52% (AcFTS [90-99%)) and 4.44% (AcFTS ≥ 99%) and was significantly increased in the two most atypical subgroups. The same applied for the second-trimester atypicality index, with risks of chromosomal aberrations of 0.76% and 4.16% in the two most atypical subgroups (AcFTS + EFW [90-99%) and AcFTS + EFW ≥ 99%, respectively).

CONCLUSIONS: As an add-on to cFTS, the atypicality index identifies women with typical measurement profiles, which may provide reassurance, whereas atypical profiles may warrant specialist referral and further investigation. In pregnancies identified as low risk on cFTS but with a highly atypical distribution of NT, PAPP-A and β-hCG, the risk of a chromosomal aberration is substantially increased. The atypicality index optimizes the interpretation of pre-existing prenatal screening profiles and is not limited to cFTS markers or EFW. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Gadsbøll K, Vogel I, Pedersen LH, et al. Atypicality index as an add-on to combined first-trimester screening for chromosomal aberrations. Ultrasound Obstet Gynecol. 2024. PMID: 38112514. doi:10.1002/uog.27562

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。